As the date for implementation of the Drug Supply Chain Security Act approaches, bio/pharma companies and contractors should focus on key areas.
Haris Kamal
Advertisement
Haris Kamal is senior vice-president of Verify Brand.
Articles by Haris Kamal
As the date for implementation of the Drug Supply Chain Security Act approaches, bio/pharma companies and contractors should focus on key areas.
Advertisement
Latest Updated Articles
Serialization Preparation Prompts Data and Business QuestionsPublished: February 1st 2017 | Updated:
- Serialization Preparation Prompts Data and Business Questions
Published: March 23rd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
3
New Targets for Clinical Trials in the European Union
4
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
5
